Skip to main content
Download PDF

Mutagenetic analysis of the biosynthetic pathway of tetramate bripiodionen bearing 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione skeleton

Microbial Cell Factories volume 23, Article number: 87 (2024) Cite this article

Abstract

Background

Natural tetramates are a family of hybrid polyketides bearing tetramic acid (pyrrolidine-2,4-dione) moiety exhibiting a broad range of bioactivities. Biosynthesis of tetramates in microorganisms is normally directed by hybrid polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) machineries, which form the tetramic acid ring by recruiting trans- or cis-acting thioesterase-like Dieckmann cyclase in bacteria. There are a group of tetramates with unique skeleton of 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione, which remain to be investigated for their biosynthetic logics.

Results

Herein, the tetramate type compounds bripiodionen (BPD) and its new analog, featuring the rare skeleton of 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione, were discovered from the sponge symbiotic bacterial Streptomyces reniochalinae LHW50302. Gene deletion and mutant complementation revealed the production of BPDs being correlated with a PKS-NRPS biosynthetic gene cluster (BGC), in which a Dieckmann cyclase gene bpdE was identified by sit-directed mutations. According to bioinformatic analysis, the tetramic acid moiety of BPDs should be formed on an atypical NRPS module constituted by two discrete proteins, including the C (condensation)-A (adenylation)-T (thiolation) domains of BpdC and the A-T domains of BpdD. Further site-directed mutagenetic analysis confirmed the natural silence of the A domain in BpdC and the functional necessities of the two T domains, therefore suggesting that an unusual aminoacyl transthiolation should occur between the T domains of two NRPS subunits. Additionally, characterization of a LuxR type regulator gene led to seven- to eight-fold increasement of BPDs production. The study presents the first biosynthesis case of the natural molecule with 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione skeleton. Genomic mining using BpdD as probe reveals that the aminoacyl transthiolation between separate NRPS subunits should occur in a certain population of NRPSs in nature.

Introduction

Natural tetramates, structurally featured with a tetramic acid (pyrrolidine-2,4-dione) moiety, are discovered from diverse organism resources exhibiting a broad range of bioactivities such as antibiotic, antitumor, antifungal and antiviral [1,2,3]. The biosynthesis of tetramates is generally directed by hybrid multimodular polyketide synthase (PKS) and nonribosomal peptide synthetases (NRPS) machineries, in which the tetramic acid moiety is formed at the terminal NRPS module via a Dieckmann cyclization [4]. The Dieckmann cyclizations occurred in bacterial tetramates biosynthetic pathways are normally catalyzed by atypical C-terminal thioesterase (TEs) domains or free-standing TE-like enzymes [4]. The genes of free-standing TE-like enzymes were discovered in the BGCs of a group of tetramates such as tirandamycin B (trdC) [5], streptolydigin (slgL) [6], α-lipomycin (lipX2) [7], lydicamycin (TPA0598_03_00810) [8], vancoresmycin (var15) [9], nocamycin I (ncmC) [10], and alchivemycin (avmQ) (Fig. 1a) [11]. Among the proteins of these genes, the Dieckmann cyclase activities of TrdC, SlgL, LipX2, and NcmC were evidenced by biochemical analysis with the N-acetoacetyl substrate mimics [12, 13]. According to the crystal structure of NcmC [13], this type of Dieckmann cyclases harbor an α/ß hydrolase fold subdomain and a four-helical bundle subdomain. The former resembles the canonical TE domain with a slightly altered catalytic triad of Cys–Asp–His compared to the Ser–Asp–His in TEs. The latter represents the unique structure of this class of Dieckmann cyclases, being proposed to participate in polyketide tail recognition [13].

As one of the key elements for tetramates biosynthesis, the NRPS module is basically composed of an adenylation (A) domain, which activates specific amino acid building block as an aminoacyl adenylate, a thiolation (T) domain, which tethers the amino acid through a 4′-phosphopantetheine (Ppant) linker, and a condensation (C) domain, which catalyzes peptide bond formation [14]. Interestingly, some NRPS assembly lines deviate from the canonical C-A-T modular architecture by recruiting the “A-less” C-T modules, which receive amino acid units from standalone A-T didomain modules by the mediation of aminoacyl-shuttling enzymes such as the atypical type II TEs from the biosynthetic pathways of cyclodepsipeptide WS9326A and pyrrolizidine alkaloid legonindolizidines [15, 16], and the aminoacyltransferase from lipopeptidolactone syringomycin biosynthetic pathway [17].

Of the natural tetramates, a family produced by microorganisms, featuring the rare 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione skeleton, remain unknown for their biosynthetic logics such as bripiodionen (BPD) from bacteria with inhibitory activity against human cytomegalovirus protease [18] and the three ones from fungus including cladodionen with cytotoxic activities against human cancer cells [19], vermelhotin with antiplasmodial activity [20], and hypoxyvermelhotin A with cytotoxicity against murine fibroblast cell line L-929 (Fig. 1b) [21]. In this study, a new analog of BPD is discovered in a sponge symbiotic Streptomyces strain. Mutagenetic analysis of the bpd BGC suggests that the BPDs biosynthesis involved an unusual aminoacyl transthiolation between separate NRPS subunits and a Dieckmann cyclization. The production of BPDs was also improved significantly by manipulating a regulator gene. The study presents the first biosynthesis case for 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione skeleton, facilitating further structural diversification through bioengineering.

Fig. 1
figure 1

The tetramates derived from the biosynthetic pathways that involve discrete TE-like Dieckmann cyclases (a) and the tetramates bearing 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione skeleton (marked in red and blue) (b)

Full size image

Results and disscussion

Discovery of BPDs from the fermentation of LHW50302

Sponge ecosystem contains rich and divers microorganisms which act as significant origins of the medicinal active molecules discovered from sponge [22, 23]. During secondary metabolite screening of the sponge symbiotic Streptomyces reniochalinae LHW50302 [24], two tetramates, including the known bripiodionen (BPD) (1) and a new BPD analog, BPD B (2), were discovered (Fig. 2a). Compound 1, obtained as a white powder, presented as a mixture of inseparable E/Z-Δ3(5) geometric isomers (1a and 1b). The molecular formula C15H20N2O4 was determined by the HRESIMS at m/z 293.1502 [M + H]+ (calcd 293.1496), accounting for seven degrees of unsaturation. The 1H and 13C NMR spectra of 1 are identified to those of BPD discovered from Streptomyces sp. WC76599 [18] (Table S3), which have two sets of resonances with a ratio of 1:3 for 1a and 1b (Fig. S6).

Compound 2, isolated as a white powder, had the molecular formula C16H22N2O4 according to the HRESIMS at m/z 307.1649 [M + H]+ (calcd 307.1652), with seven degrees of unsaturation. Similar to compound 1, compound 2 was obtained as a mixture of two inseparable geometric isomers 2a (E-Δ3(5)) and 2b (Z-Δ3(5)) in a 1:3 ratio (Fig. S7). The 1H and 13C NMR data of 2 were almost identical to those of 1 with the exception that the methyl at C-10 in 1 (δC 18.8/19.2, CH3-15) (Table S3) was replaced with the ethyl in 2 (δC 23.8/23.9, CH2-15; δC 13.4/13.1, CH3-16) (Fig. 2, Table S4). This assignment was further supported by the COSY correlation between H2-15 and H3-16, and the HMBC correlation from H3-16 to C-10 (Fig. 2b, Table S4). The NMR data of 2a and 2b were nearly identical with the exception of chemical shift at H-6 (δH−6 7.46/7.62) for 2a/2b (Table S4), which could be caused by the deshielding effect of C-2 carbonyl.

Fig. 2
figure 2

Structures of compounds 1 and 2 (a), and the 1H-1H COSY and HMBC correlations of 2 (b)

Full size image

Identification of BPDs biosynthetic gene cluster in LHW50302

Natural tetramate molecules are generally constructed from polyketide and α-amino acid units via the concerted actions of PKS and NRPS assemblies. In bacteria, the tetramate scaffold is usually formed from a nascent linear product tethered on NRPS module via the Dieckmann cyclization catalyzed by an atypical C-terminal thioesterase (TE) domain or free-standing TE-like enzyme [4]. With the information, BLAST search against LHW50302 genome was performed using TrdC as the query seed, which was identified as a Dieckmann cyclase in the biosynthetic pathway of tirandamycin from Streptomyces sp. SCSIO 1666 [12]. The analysis led to discovery of an open reading frame (ORF), named as bpdE, showing 36% protein sequence identity to TrdC. The bpdE gene is located within an unknown PKS-NRPS BGC, termed as bpd BGC (Fig. 3a), which basically harbors two PKS genes bpdA and bpdB and two NRPSs genes bpdC and bpdD (Table 1). Based on antiSMASH analysis [25] and the structural features of BPDs, the PKS-NRPS assembly line of BPDs should be initiated with the starting unit of isobutyryl-CoA for compound 1 or 2-methylbutyryl-CoA for compound 2 and then proceeded by condensations of one methymalonyl-CoA, two malonyl-CoAs, and one Asn to yield a nascent hybrid polyketide chain, which could first receive the BpdE-catalyzed heterocyclization to yield the pyrrolidine-2,4-dione core and then undergo a spontaneous pyran-ring formation (Fig. 3b).

Fig. 3
figure 3

Gene organization of bpd BGC (a) and the proposed biosynthetic pathway of compounds 1 and 2 (b). The proposed aminoacyl transthiolation between the BpdD and BpdC NRPS subunits is highlighted by a frame; The inactive A domain in BpdC is shown by white circle

Full size image
Table 1 Deduced functions of the ORFs in bpd BGC
Full size table

To identify the correlation of bpd BGC and compounds 1 and 2, the gene cassette bpdE-C consisting of bpdC, bpdD, bpdE and orf4 was deleted from the chromosome of LHW50302 via homologous recombination (Fig. 4a). As expected in HPLC analysis of the fermentation extracts (Fig. 4b), the resulting mutant ΔbpdE-C indeed lost the production of 1 and 2, which was then restored when the bpdE-C cassette was delivered back into ΔbpdE-C via the plasmid pRJ453 constructed from an integrative vector. The results therefore confirmed that the production of 1 and 2 was correlated to bpd BGC.

Fig. 4
figure 4

Identification of bpd BGC in LHW50302. a) Deletion of bpdE-C gene cassette via double-crossover homologous recombination; b) HPLC analysis of compounds 1 and 2 from the resultant mutant and gene complementation strain

Full size image

Identification of the Dieckmann cyclase gene bpdE by site-directed mutagenetic analysis

Owing to lack of C-terminal TE domain, the tetramic acid core in BPDs should apparently be formed by a trans-working chain offloading cyclase, for instance the BpdE homologous to TrdC-type Dieckmann cyclase [4]. According to DALI search against the Protein Data Bank (PDB), the BpdE protein structure modeled by AlphaFold2 is most similar (2.1 Å RMSD for 253 Cα atoms) to NcmC (PDB 6E6Y) (Fig. S1), which was biochemically characterized as an offloading Dieckmann cyclase installing a tetramate headgroup in the hybrid polyketide/nonribosomal-peptide nocamycin from Saccharothrix syringae [13]. The canonical motif Cys-Asp-His in TrdC-type enzymes is recognized in BpdE by multiple sequence alignment of BpdE with the discrete TE-like Dieckmann cyclases from tetramate biosynthetic pathways (Fig. S2). According to enzymatic mechanism of TE-like Dieckmann cyclases proposed according to protein structure and site-mutation analysis of NcmC [13], the linear backbone of BPDs should be transthiolated from the HS-Ppant arm of T4b domain to the Cys89 site of BpdE; a nucleophilic cyclization from C4 to C1 is then initiated by the substrate C4 enol, which is activated by the catalytic base of His245 stabilized by Asp116 or by the proton-shuttle model of Tyr204 and one water (Fig. 5a).

Fig. 5
figure 5

Identification of the Dieckmann cyclase gene bpdE by site-directed mutagenetic analysis. a) The documented proposal for the enzymatic mechanism of TE-like Dieckmann cyclases, in which the key active sites are labeled according to BpdE. b) The modeled protein structure of BpdE docked with a linear BPD precursor chain tethered in the Cys89 site of ligand binding pocket. c) HPLC analysis of compounds 1 and 2 from the RJ46 (ΔbpdE-C) strain complemented with the modified bpdE-C gene cassettes bearing sit-directed mutations in bpdE

Full size image

To identify the four active sites in BpdE (Fig. 5b), the site mutations of C89A, H245N, D116A, and Y204F were generated based on the bpdE-C gene cassette in the plasmid pRJ453, which was successfully used for complementation of the ΔbpdE-C mutant strain (Fig. 4b). As expected, the four resultant pRJ453 variants gave no complementary effects to the ΔbpdE-C mutant (Fig. 5c), compared to the significant production recovery of compounds 1 and 2 upon introduction of pRJ453, therefore confirming their essential roles for the catalytic activity of BpdE. Moreover, the mutation C89S was also generated to test whether BpdE can employ Ser to anchor linear intermediate by oxoester bound, instead of the thioester bound of Cys active site. The mutation is plausible due to that the Ser–Asp–His catalytic triad is also discovered in the C-terminal TE domains possessing Dieckmann cyclase activities in some bacterial tetramate biosynthetic pathways [4]. Interestingly, the pRJ453 variant containing C89S mutation failed to restore the production of compounds 1 and 2 in ΔbpdE-C (Fig. 5c), suggesting different catalytic mechanisms remained to be elucidated in two types of Dieckmann cyclases.

Site-directed mutagenetic analysis of the A and T domains within the atypical NRPS module encoded by bpdC and bpdD

According to the structures of BPDs, one Asn elongation unit should be incorporated at the end of the PKS-NRPS assembly line of BPDs. Interestingly, the expected C-terminal NRPS module seemed to be consisted by two discrete proteins BpdC and BpdD, in which BpdC contains C-A-T domains and BpdD is an A-T didomain (Fig. 3). Detail analysis suggested that the A domain in BpdC should be inactive due to the naturally occurred mutations of D552P and K792R (Fig. S3a), which are located in the conservative Asp and Lys sites essential for the catalysis of A domain [26]. Thus, the adenylation of Asn and subsequent aminoacyl thiolation could be carried out by the A domain of BpdD, which contains the Asn specificity-conferring code according to the prediction from antiSMASH. Moreover, both BpdC and BpdD contain bioinformatically intact T domains, T4a and T4b (Fig. S3b), therefore raising a question whether each of them was required for the NRPS module.

To address the point, the A domain from bpdC and the two T domains from bpdD and bpdC were individually examined by site-directed mutagenetic analysis. For the investigation, the pRJ453 containing bpdE-C genes cassette was used as parent plasmid to generate these mutations. To convincingly inactivate the A domain in BpdC, the R792A mutation in bpdC was generated targeting the canonical Arginine active site of A domain [26]. To inactivate the T4a and T4b domains, the S852A mutation in bpdC and S551A in bpdD were generated to abolish the Serine active site covalently bonded to the Ppant cofactor [27]. These pRJ453 variants were individually introduced into the ΔbpdE-C mutant strain and the effects of site-mutations were evaluated by determining the production of compound 1 from the recombinant strains. According to HPLC analysis, the R792A mutation in bpdC did not influence the restored production of 1, whereas each of S551A in bpdD and S852A in bpdC led to abolished production of 1 (Fig. 6). These results therefore confirm that the A domain in BpdC is naturally inactive and the NRPS module in BPDs biosynthesis should work with two independent T domains.

Fig. 6
figure 6

HPLC analysis of compounds 1 and 2 from the RJ46 (ΔbpdE-C) strain complemented with the modified bpdE-C gene cassette bearing the sit-mutations R792A in bpdC, S551A in bpdD, and S852A in bpdC, respectively. The domains introduced with target site-mutations are indicated by crosses

Full size image

Unusual aminoacyl transthiolation in the atypical NRPS module of BPDs biosynthesis

As a speculation based on above mutagenetic analysis of the NRPS domains, incorporation of Asn unit should be performed by an atypical NRPS module, in which the A-T4a didomain of BpdD activates and loads an Asn and then the Asn aminoacyl group is shuttled from T4a domain to the HS-Ppant arms of T4b domain in BpdC. The C domain of BpdC then catalyzed the aminoacyl condensation based on T4b domain (Fig. 3b). The aminoacyl group transthiolation between two separate NRPS subunits were observed in rare cases of bacterial secondary metabolites biosynthesis. So far, the documented cases include the aminoacyltransferases CmaE and SyrC from the biosynthetic pathways of cyclopropyl amino acid coronamic acid and lipopeptidolactone syringomycin [17, 28] and the atypical type II TEs WS5/WS20 and LgnA from the biosynthetic pathways of cyclodepsipeptide WS9326A [15] and pyrrolizidine alkaloid legonindolizidines [16].

Given the speculation, the TEII homologous gene bpd1 at left side of bpd BGC (Fig. 3a), showing 36% identity to LgnA, was investigated by gene deletion. However, the production of 1 and 2 was not affected in the fermentation extract of resultant Δbpd1 mutant strain according to HPLC–MS analysis (Fig. S4). Moreover, BLAST search using SyrC as query seed did not reveal obvious aminoacyltransferase homologous genes from the genome of LHW50302. As an alternative mechanism, the A-T didomain of BpdD can independently carry out the aminoacyl transthiolation between two T domains since this type of A-T didomain genes are present in a certain population of NRPS BGCs according to the survey of documented BGCs of NRPSs (Fig. S5), though their evolutional significance remined to be investigated.

Boosting BPDs production by enhancing the transcription level of LuxR type regulator gene

Protein sequence analysis suggests the product of bpd4 gene belonging to the LuxR family transcription regulators, which are characterized by the C-terminal helix-turn-helix (HTH) domain [29, 30]. To functionally identify bpd4, the ORF of bpd4 was deleted from the bpdE-C cassette in pRJ453, and when the resultant plasmid was introduced into ΔbpdE-C strain, the production of compounds 1 and 2 was totally destroyed (Fig. 7a), suggesting Bpd4 as a strict regulator in BPDs biosynthesis. The result encouraged us to boost BPDs production by overexpression of bpd4 gene based on an integrative vector in LHW50302 strain. The ORF of bpd4 gene was then engaged with a strong and constitutive promoter kasOp*, which was demonstrated with good compatibilities in a broad array of Actinomyces hosts [31]. As expected, seven- to eight-fold yield improvement of compound 1 was accomplished upon overexpression of bpd4 in LHW50302 according to HPLC analysis of the fermentation extracts (Fig. 7b).

Fig. 7
figure 7

Improving BPD production by overexpressing the regulator gene bpd4. a) HPLC analysis of compound 1 from the RJ46 (ΔbpdE-C) strain complemented with a bpdE-C cassette derivative (Δbpd4_bpdE-C) with the regulator gene bpd4 deleted. b) HPLC analysis of compound 1 from the LHW50302 (W.T) introduced with extra copy of bpd4 gene engaged with a constitutive and strong promoter kasOp*. The production improvement levels of 1a and 1b were evaluated by calculating the target peak areas shown in the table at bottom

Full size image

Concluding remarks

Two tetramate type compounds, including the known BPD and a new BPD analog, featuring the rare skeleton of 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione, were discovered from sponge symbiotic Streptomyces reniochalinae LHW50302. Gene deletion and mutant complementation demonstrated that the production of BPDs was directed by a PKS-NRPS type BGC, in which a Dieckmann cyclase gene bpdE was identified by sit-directed mutations. Site-directed mutagenetic analysis of the NRPS domains suggests that the tetramic acid moiety of BPDs should be formed on an atypical NRPS module constituted by two separate subunits, in which an aminoacyl transthiolation should occur between two T domains. In addition, characterization of a LuxR type positive regulator gene led to seven- to eight-fold increasement of the BPD production. The study presents the first biosynthetic pathway of the natural product containing 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione skeleton. Moreover, genomic mining using BpdD as probe reveals a certain population of identified NRPSs containing both freestanding A-T didomain and A-less module, implying the generality of this type of aminoacyl transthiolation between NRPS subunits in nature.

Materials and methods

DNA manipulation and chemicals

Primers synthesis and DNA sequencing were ordered from Shanghai Sangon Biotech (China). DNA fragments were assembled by using 2 × Ezmax-Muli CloneMix Plus (Shanghai Tolo Biotech, China). PCR amplifications were carried out by using KOD OnePCR Master Mix (TOYOBO) for gene cloning and by using 2 × FastTaq Master Mix (Shanghai Bioroot Biotech) for colony screening. Plasmid DNA extraction was performed by using plasmid mini kit (Shanghai Generay Biotech). The genomic DNA used as a PCR template was prepared by using 10% Chelex 100 resin (Bio-Rad) solution.

Bactetial strains, culture conditions, and plasmids

E. coli DH10B was used as a host for plasmid construction. E.coli ET12567 strain containing pUZ8002 plasmid was used for introducing plasmid into Streptomyces. The sponge symbiotic S. reniochalinae LHW50302 [24] was used as the starting strain to investigate bpd BGC. E. coli strains were grown at 37 °C in Luria-Bertani (LB) broth (1% tryptone, 0.5% yeast extract, 0.5% NaCl) or the solid LB medium (plus 1.5% agar) supplemented with corresponding antibiotics. SFM agar medium (2% soyean flour, 2% D-mannitol, 2% agar, pH 7.2) was used for conjugation and mutant screening. For Streptomyces fermentation, the TSBY medium (3% tryptone soy broth, 0.5% yeast extract, 10% sucrose, 0.1% antifoam) was used for seed culture and the CSG medium (2% starch, 1% glucose, 3% sea salt, 0.4% casamino acid, and 0.1% antifoam) was used for final fermentation. The small-scale fermentation was performed in a 250 mL conical flask fitted with a metal spring, 50 mL of CSG medium, and 2% (v/v) inoculation of 3 d TSBY culture, incubating at 30 °C and 220 rpm for 5 d. The large-scale fermentation was performed by using 500 mL conical flask, 150 mL CSG medium and 5% (v/v) inoculation of 3 d TSBY culture, and then incubated at 30 °C and 220 rpm for 7 d. Plasmids used in this study are listed in Table S2.

Analytical methods

For routine HPLC–MS analysis, 7 mL of fermentation broth was extracted with an equal volume of ethyl acetate and then 5 mL organic phase was collected and dried via nitrogen blowing. The dryness was redissolved in 800 µL methanol and centrifuged at 12,000 rpm for 5 min before injecting 20 µL supernatant for HPLC–MS analysis. The HPLC–MS analysis was conducted on a Waters HPLC coupled with a Waters Acquity QDa detector. For fermentation analysis, a Xbridge C18 column (250 mm × 4.6 mm, 5 μm) was eluted with the mobile phase of acetonitrile and H2O (0.1% formic acid, v/v) at a flow rate of 0.8 mL/min in the program of 30–50% for 10 min and then 95% for 12 min. The mass spectrometer ran in positive ionization mode scanning from m/z 200 to 1250. For HRMS analysis, a Waters XeVO G2-XS Q TOF mass spectrometer was conducted in positive ionization mode, scanning from m/z 100 to 1200. NMR spectra were recorded on Bruker 600 MHz in DMSO-d6. Chemical shifts (δ) were obtained in reference to tetramethylsilane (TMS) at 0.00 ppm.

Purification of compounds 1 and 2

To prepare compounds 1 and 2 for structural elucidation, 24 L fermentation broth of LHW50302 was extracted three times with equal volume of ethyl acetate (0.1% formic acid, v/v). The combined organic phases were degreased with hexane and concentrated under vacuum to yield 15 g syrup extract. The extract was subjected to a vacuum liquid chromatography column loaded with silica gel (200–300 mesh) using a stepwise elution with CH2Cl2/MeOH (1:1, v/v) to afford five fractions (Fr. B1-B5). Guided by HPLC–MS analysis, the B3 fraction (1 g) was selected for further separation by using medium-pressure preparative liquid chromatography (MPLC) equipped with an ODS chromatography column (Santai Technologies, Inc., Spherical C18, 20–45 μm, 100 Å) in an elution condition of 15 mL/min and 10–100% MeOH/H2O (0.1% formic acid, v/v) for 3 h to afford sixteen subfractions (Fr. B3A-B3P). Then the fraction B3K (250 mg) was further separated over HPLC (Waters Xbridge C18, 10 × 250 mm, 3.0 mL/min, 35% MeOH/H2O) to to yield 2 mg of 1a, 4 mg of 1b as well as B3L (33 mg) was purified with HPLC (Waters Xbridge C18, 10 × 250 mm, 3.0 mL/min, 29% CH3CN/H2O) to obtain 1 mg of 2a and 2 mg of 2b.

Deletion of the bpdE-C gene cassette

To generate the platform mutant strain RJ46 (ΔbpdE-C), the bpdE-C gene cassette (Fig. 4a) was deleted from the chromosome of LHW50302. To construct the plasmid for introducing double-crossover homologous recombination, a 1227 bp left arm and a 1412 bp right arm were amplified from the genomic DNA of LHW50302, respectively (see primers in Table S1). By using Gibson assembly, the two PCR fragments were assembled with the E. coli–Streptomyces shuttle plasmid pYH7 [32] linearized by HindIII and NdeI. The resultant pRJ205 plasmid was introduced into LHW50302 strain by conjugation via the transitional host E. coli ET12567 containing helper plasmid pUZ8002. The target mutant strains were screened by colony PCR from the apramycin-sensitive colonies prepared after two rounds of propagation on no antibiotics SFM plates. Finally, the mutant strain was reconfirmed by sequencing the PCR products.

Sit-directed mutagenetic analysis of bpdC, bpdD, and bpdE

The RJ46 mutant was used as a platform host to evaluate the effects of gene mutations within bpdE-C cassette by using the mutated bpdE-C gene cassette for complementation of RJ46. To this end, the bpdE-C gene cassette amplified from LHW50302 was assembled with an integrative vector pIB139 [33] at NdeI and EcoRI sites by using Gibson assembly yielding plasmid pRJ358. Due to failed complementation by using pRJ358 in RJ46 strain, the transcription cassette of orf3 (upstream the bpdE-C gene cassette) amplified from LHW50302 was introduced into pRJ358 at NsiI and NdeI sites by using Gibson assembly. The resulting plasmid pRJ453 was used as starting material for generating mutations in the bpdE-C gene cassette such as the sit-directed mutations in bpdE (C89S, C89A, D116A, Y204F, or H245N), bpdC (S852A or R792A) and bpdD (S551A) and the gene deletion mutation in bpd4 (see primers in Table S1). The resulting plasmid (Table S2) was introduced into the RJ46 via conjugation as described above. The target strains were confirmed by sequencing the PCR products.

Gene deletion and overexpression of bpd4

The bpd4 gene deletion mutation was generated based on the complementary plasmid pRJ453. To this end, pRJ453 was cut open with BsrGI and SfiI and then repaired with a partial fragment of bpdD (see primers in Table S1) by using Gibson assembly yielding pRJ510. To constructing the bpd4 gene overexpression cassettes, the PCR fragment of bpd4 was assembled with the fragment of promoter kasOp* amplified from pRJ252 [34] at the sites of NsiI and EcoRI in pIB139 (see primers in Table S1). The resulting plasmids pRJ510 and pRJ551 were introduced into RJ46 and LHW50302 by conjugation, respectively.

Gene deletion of the bpd1

To delete bpd1 gene, two PCR fragments, 1411 bp left arm and 1419 bp right arm, were amplified from LHW50302 for homologous recombination (see primers in Table S1). The PCR products were assembled with pYH7 (HindIII, NdeI) by Gibson assembly. The resulting plasmid pRJ509 was introduced into LHW50302 via conjugation. The mutant strain Δbpd1 was screened out by using same strategy described as above.

Protein structure modeling and ligand docking analysis

The BpdE structure modeled by AlphaFold2 was submitted to Dali server [35] for structural similarity analysis. The ligand docking analysis of BpdE was performed by using Autodock. The structure complex of protein-ligand was read and analyzed by PyMOL2.

Data availability

All datasets were generated or analysed during the current study.

References

  1. Mo X, Li Q, Ju J. Naturally occurring tetramic acid products: isolation, structure elucidation and biological activity. RSC Adv. 2014;4:50566–93.

    Article  ADS  CAS  Google Scholar 

  2. Schobert R, Schlenk A. Tetramic and tetronic acids: an update on new derivatives and biological aspects. Bioorg Med Chem. 2008;16:4203–21.

    Article  CAS  PubMed  Google Scholar 

  3. Jiang M, Chen S, Li J, Liu L. The Biological and Chemical Diversity of Tetramic Acid compounds from Marine-Derived microorganisms. Mar Drugs 2020, 18.

  4. Mo X, Gulder TAM. Biosynthetic strategies for tetramic acid formation. Nat Prod Rep. 2021;38:1555–66.

    Article  CAS  PubMed  Google Scholar 

  5. Carlson JC, Fortman JL, Anzai Y, Li S, Burr DA, Sherman DH. Identification of the Tirandamycin Biosynthetic Gene Cluster from Streptomyces sp. 307-9. ChemBioChem. 2010;11:564–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Olano C, Gómez C, Pérez M, Palomino M, Pineda-Lucena A, Carbajo RJ, Braña AF, Méndez C, Salas JA. Deciphering biosynthesis of the RNA polymerase inhibitor streptolydigin and generation of glycosylated derivatives. Chem Biol. 2009;16:1031–44.

    Article  CAS  PubMed  Google Scholar 

  7. Bihlmaier C, Welle E, Hofmann C, Welzel K, Vente A, Breitling E, Müller M, Glaser S, Bechthold A. Biosynthetic gene cluster for the polyenoyltetramic acid α-lipomycin. Antimicrob Agents Chemother. 2006;50:2113–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Komaki H, Ichikawa N, Hosoyama A, Fujita N, Igarashi Y. Draft genome sequence of marine-derived Streptomyces sp. TP-A0598, a producer of anti-MRSA antibiotic lydicamycins. Stand Genomic Sci 2015, 10.

  9. Kepplinger B, Morton-Laing S, Seistrup KH, Marrs ECL, Hopkins AP, Perry JD, Strahl H, Hall MJ, Errington J, Allenby NEE. Mode of Action and Heterologous expression of the natural product antibiotic Vancoresmycin. ACS Chem Biol. 2017;13:207–14.

    Article  PubMed  Google Scholar 

  10. Mo X, Shi C, Gui C, Zhang Y, Ju J, Wang Q. Identification of nocamycin biosynthetic gene cluster from Saccharothrix syringae NRRL B-16468 and generation of new nocamycin derivatives by manipulating gene cluster. Microb Cell Fact 2017, 16.

  11. Zhu HJ, Zhang B, Wei W, Liu SH, Xiang L, Zhu J, Jiao RH, Igarashi Y, Bashiri G, Liang Y et al. AvmM catalyses macrocyclization through dehydration/Michael-type addition in alchivemycin a biosynthesis. Nat Commun 2022, 13.

  12. Gui C, Li Q, Mo X, Qin X, Ma J, Ju J. Discovery of a New Family of Dieckmann Cyclases essential to Tetramic Acid and Pyridone-based Natural products Biosynthesis. Org Lett. 2015;17:628–31.

    Article  CAS  PubMed  Google Scholar 

  13. Cogan DP, Ly J, Nair SK. Structural basis for enzymatic off-loading of Hybrid Polyketides by Dieckmann Condensation. ACS Chem Biol. 2020;15:2783–91.

    Article  CAS  PubMed  Google Scholar 

  14. Süssmuth RD, Mainz A. Nonribosomal peptide synthesis—principles and prospects. Angew Chem Int Ed. 2017;56:3770–821.

    Article  Google Scholar 

  15. Kim MS, Bae M, Jung YE, Kim JM, Hwang S, Song MC, Ban YH, Bae ES, Hong S, Lee SK, et al. Unprecedented noncanonical features of the nonlinear nonribosomal peptide synthetase Assembly Line for WS9326A Biosynthesis. Angew Chem Int Ed. 2021;60:19766–73.

    Article  CAS  Google Scholar 

  16. Wang S, Brittain WDG, Zhang Q, Lu Z, Tong MH, Wu K, Kyeremeh K, Jenner M, Yu Y, Cobb SL, Deng H. Aminoacyl chain translocation catalysed by a type II thioesterase domain in an unusual non-ribosomal peptide synthetase. Nat Commun 2022, 13.

  17. Singh GM, Vaillancourt FH, Yin J, Walsh CT. Characterization of SyrC, an aminoacyltransferase shuttling threonyl and chlorothreonyl residues in the Syringomycin Biosynthetic Assembly line. Chem Biol. 2007;14:31–40.

    Article  CAS  PubMed  Google Scholar 

  18. Shu YZ, Ye QM, Kolb JM, Huang S, Veitch JA, Lowe SE, Manly SP. Bripiodionen, a new inhibitor of human cytomegalovirus protease from Streptomyces sp. WC76599. J Nat Prod. 1997;60:529–32.

    Article  CAS  PubMed  Google Scholar 

  19. Zhu G, Kong F, Wang Y, Fu P, Zhu W. Cladodionen, a cytotoxic hybrid polyketide from the Marine-Derived Cladosporium sp. OUCMDZ-1635. Mar Drugs 2018, 16.

  20. Kasettrathat C, Ngamrojanavanich N, Wiyakrutta S, Mahidol C, Ruchirawat S, Kittakoop P. Cytotoxic and antiplasmodial substances from marine-derived fungi, Nodulisporium sp. and CRI247-01. Phytochemistry. 2008;69:2621–6.

    Article  CAS  PubMed  Google Scholar 

  21. Kuhnert E, Heitkämper S, Fournier J, Surup F, Stadler M. Hypoxyvermelhotins A–C, new pigments from Hypoxylon lechatii sp. nov. Fungal Biology. 2014;118:242–52.

    Article  CAS  PubMed  Google Scholar 

  22. Hong L-L, Ding Y-F, Zhang W, Lin H-W. Chemical and biological diversity of new natural products from marine sponges: a review (2009–2018). Mar Life Sci Technol. 2022;4:356–72.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  23. Liu M, Zhang X, Li G. Structural and biological insights into the Hot-Spot Marine Natural products reported from 2012 to 2021. Chin J Chem. 2022;40:1867–89.

    Article  CAS  Google Scholar 

  24. Li L, Wang J, Zhou Y-j, Lin H-w. Lu Y-h: Streptomyces reniochalinae sp. nov. and Streptomyces diacarni sp. nov., from marine sponges. Int J Syst Evol MicroBiol. 2019;69:99–104.

    Article  CAS  PubMed  Google Scholar 

  25. Blin K, Shaw S, Augustijn HE, Reitz ZL, Biermann F, Alanjary M, Fetter A, Terlouw BR, Metcalf WW, Helfrich EJN, et al. antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic Acids Res. 2023;51:W46–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kries H, Wachtel R, Pabst A, Wanner B, Niquille D, Hilvert D. Reprogramming nonribosomal peptide synthetases for clickable amino acids. Angew Chem Int Ed. 2014;53:10105–8.

    Article  CAS  Google Scholar 

  27. Weber T, Baumgartner R, Renner C, Marahiel MA, Holak TA. Solution structure of PCP, a prototype for the peptidyl carrier domains of modular peptide synthetases. Struct Fold Des. 2000;8:407–18.

    Article  CAS  Google Scholar 

  28. Strieter ER, Vaillancourt FH, Walsh CT. CmaE: a transferase shuttling aminoacyl groups between carrier protein domains in the coronamic acid biosynthetic pathway. Biochemistry. 2007;46:7549–57.

    Article  CAS  PubMed  Google Scholar 

  29. Li Z, Li X, Xia H. Roles of LuxR-family regulators in the biosynthesis of secondary metabolites in Actinobacteria. World J Microbiol Biotechnol 2022, 38.

  30. Chen J, Xie JP. Role and regulation of bacterial LuxR-Like regulators. J Cell Biochem. 2011;112:2694–702.

    Article  CAS  PubMed  Google Scholar 

  31. Wang W, Li X, Wang J, Xiang S, Feng X, Yang K. An Engineered strong promoter for Streptomycetes. Appl Environ Microbiol. 2013;79:4484–92.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  32. Sun Y, He X, Liang J, Zhou X, Deng Z. Analysis of functions in plasmid pHZ1358 influencing its genetic and structural stability in Streptomyces lividans 1326. Appl Microbiol Biotechnol. 2009;82:303–10.

    Article  CAS  PubMed  Google Scholar 

  33. Wilkinson CJ, Hughes-Thomas ZA, Martin CJ, Böhm I, Mironenko T, Deacon M, Wheatcroft M, Wirtz G, Staunton J, Leadlay PF. Increasing the efficiency of heterologous promoters in actinomycetes. J Mol Microbiol Biotechnol. 2002;4:417–26.

    CAS  PubMed  Google Scholar 

  34. Zhou L, Shen Y, Chen N, Li W, Lin H-w, Zhou Y. Targeted accumulation of selective anticancer depsipeptides by reconstructing the precursor supply in the neoantimycin biosynthetic pathway. Bioresources Bioprocess 2021, 8.

  35. Holm L, Rosenström P. Dali server: conservation mapping in 3D. Nucleic Acids Res. 2010;38:W545–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was financially supported by the National Key Research and Development Program of China (No. 2023YFA0914202), the National Natural Science Foundation of China (Nos. 32070070, 32211530074, and 31929001), the innovative research team of high-level local universities in Shanghai, and the SciTech Funding by CSPFTZ Lingang Special Area Marine Biomedical Innovation Platform. H. D. thanks Royal Society-NSFC international exchange grant (IEC\NSFC\211349).

Author information

Authors and Affiliations

  1. Research Center for Marine Drugs, Department of Pharmacy, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China

    Haixia Zang, Yijia Cheng, Mengjia Li, Lin Zhou, Li-Li Hong, Hou-Wen Lin & Yongjun Zhou

  2. Department of Chemistry, University of Aberdeen, Aberdeen, AB24 3UE, UK

    Hai Deng

Authors
  1. Haixia Zang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yijia Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mengjia Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Li-Li Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hai Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hou-Wen Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yongjun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization, Y. Z.; Methodology, Y. Z.; Investigation, H. Z., Y. C., L. Z., and M. L.; Writing – Original Draft, H. Z. and Y. Z.; Writing – Review & Editing, Y. Z., L.L. H., and H. D.; Funding Acquisition, Y. Z. and H.W. L.; Resources, H.W. L.; Supervision, Y. Z.

Corresponding authors

Correspondence to Hou-Wen Lin or Yongjun Zhou.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Additional file: Table S1 to S4 and Fig. S1 to S7

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zang, H., Cheng, Y., Li, M. et al. Mutagenetic analysis of the biosynthetic pathway of tetramate bripiodionen bearing 3-(2H-pyran-2-ylidene)pyrrolidine-2,4-dione skeleton. Microb Cell Fact 23, 87 (2024). https://0-doi-org.brum.beds.ac.uk/10.1186/s12934-024-02364-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12934-024-02364-7

Keywords

Microbial Cell Factories

ISSN: 1475-2859

Contact us